25 Oct 2022 , 12:34 AM
Revenue growth was 19.18% in sequential terms. The company, which is part of the Biocon group, is into contract research which is also called the CRAMS model.
The company reported improved cash flow from operations in the first half of the year on the back of improved working capital metrics.
The company has declared a final dividend of Rs1 per share for FY22 and also special dividend of Rs0.50.
The cost controls on the raw material front made up for the increase in employee costs yoy. The profit growth also looks magnified due to the Rs30.7 crore exceptional loss in the September 2021 quarter due to reversal of SEIS claim.
PAT margins were higher at 13.28% in the Sep-22 quarter compared to 10.93% in the Sep-21 quarter and also higher than 11.47% in Jun-22 quarter.
Financial highlights for Sep-22 compared yoy and sequentially
Syngene International | |||||
Rs in Crore | Sep-22 | Sep-21 | YOY | Jun-22 | QOQ |
Total Income (Rs cr) | ₹ 768.10 | ₹ 610.20 | 25.88% | ₹ 644.50 | 19.18% |
Net Profit (Rs cr) | ₹ 102.00 | ₹ 66.70 | 52.92% | ₹ 73.90 | 38.02% |
Diluted EPS (Rs) | ₹ 2.53 | ₹ 1.63 | ₹ 1.83 | ||
Net Margins | 13.28% | 10.93% | 11.47% |
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.